Q
Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

24,979 signal articles · 251 in last 24h · 119,125 total before filter · latest 28m ago
251last 24h
1549last 7d
261● bullish (7d)
160● bearish (7d)
205publishers
AllMacro299Earnings616M&A105Regulatory21Product14Analyst22
✕ clear all filterssentiment: bearishSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Bloomberg36d agobearish
Lucid Sinks on Report EV Maker’s Considering Possible Bankruptcy

(Bloomberg) -- Lucid Group Inc. shares sank Tuesday after a news report said the electric vehicle maker is working with a restructuring advisor and weighing options that include filing for bankruptcy protection or going private.Most Read from BloombergUS Hits Iran With Strikes, Blockade as Trump Plans Hormuz ChargeUS CPI Falls for the First Time Since 2020, Core Gauge FlatA Cocaine Bust in Spain Leads All the Way to Wall Street‘We Faltered’: IBM Plunges Most Since 1968 on Sales MissTrump Shelves

Citi Stock Drops on Expense Concerns
The Wall Street Journal36d agobearish
Citi Stock Drops on Expense Concerns

Citigroup reported a robust second quarter, with its profits up double-digits. But its stock fell after executives indicated the bank would use the good times to invest in itself. “A stronger environment isn't just upside to report,” Citi CEO Jane Fraser said on a call with Wall Street analysts.

European Defense Groups to Work on Ballistic-Missile Shield
The Wall Street Journal36d agobearish
European Defense Groups to Work on Ballistic-Missile Shield

Destinus, MBDA, Safran, Airbus and Thales said they had signed a letter of intent to establish a consortium for the development of the Bliksem EXO system to strike down ballistic missiles, which can travel at hypersonic speeds above the atmosphere.

Investing.com36d agobearish
Biogen tumbles 8.7% as breakthrough Alzheimer’s data is clouded by dosing paradox

Investing.com -- Biogen Inc. (NASDAQ:BIIB) shares fell nearly 9% following the Phase 2 CELIA readout of its highly anticipated Alzheimer’s therapy, diranersen. While the drug achieved a major scientific milestone by robustly clearing tau pathology, an unexpected inverse dose response—where the lowest dose performed the best—left Wall Street analysts confused and triggered a sell-off. Diranersen missed its primary endpoint: proving a dose-dependent response on the CDR-SB, a key measure of cogniti

Bloomberg36d agobearish
Citi Shares Drop as CEO Warns of Higher Cost from Investments

(Bloomberg) -- Citgroup Inc.’s shares erased earlier gains as Chief Executive Officer Jane Fraser said the bank would “lean in with additional investments and other actions” if economic conditions remain favorable.Most Read from BloombergUS Hits Iran With Strikes, Blockade as Trump Plans Hormuz ChargeUS CPI Falls for the First Time Since 2020, Core Gauge FlatLindsey Graham, Senate Hawk Turned Trump Ally, Dies at 71Trump Embraces Australian Retirement System Backed by Larry FinkA Cocaine Bust in

IBM’s Tumble Drags on Software, IT Stocks
The Wall Street Journal36d agobearish
IBM’s Tumble Drags on Software, IT Stocks

IBM stock is having one of its worst days ever – and is dragging some other names in software and IT along with it. Shares of software and professional-services firms including Accenture, Gartner, Workday and ServiceNow were all trading lower Tuesday morning.

IBM shares plummet as preliminary second quarter results miss expectations
Proactive36d agobearish
IBM shares plummet as preliminary second quarter results miss expectations

International Business Machines Corp (NYSE:IBM) shares fell about 25% to $217 on Tuesday after the company released preliminary second quarter 2026 results that came in below Wall Street expectations and warned that an unexpected shift in customer spending weighed on its software and...